Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)

Clinical trial NCT02194595 · COMPLETED

Trial details

NCT number: NCT02194595
Sponsor: Mount Sinai Hospital, Canada
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2014-09-01
Primary completion: 2021-12-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.